A "powder" consisting of a drug in an amorphous state stabilized by a carrier (e.g., polymer). The net result is that a significant increase in bioavailability of the drug is achieved (over the drug, per se) when the powder is incorporated in a dosage form (e.g., tablet). An innovative technology developed by Dr. Navnit Shah.
Glossary
Microprecipitated Bulk Powder (MBP)
03.25.13
-
Drug Development
Solving the Pharma Talent Crunch
Addressing talent shortages in today's pharmaceutical sectorJim Sykes, Managing Director, Pharmaceutical & Life Sciences, Alexander Mann Solutions
-
Promotions & Moves
Akebia Therapeutics Names CMO
Jain to lead clinical development of the company’s HIF pipeline
-
Breaking News | Drug Development | Industry News | Preclinical Outsourcing
Pierre Fabre Buys Igenica Immuno-oncology Assets
Deal reinforces Pierre Fabre’s pipeline in oncology, its primary R&D focus area
-
Breaking News | Facilities | Industry News | Solid Dosage/Creams/Ointments | Solid Dosage/Semi-solids
Recro Gainesville Expands Mfg. Capabilities
Installs new tableting equipment and grows development team
-
Clinical Trials | CRO News | Information Technology
CROS NT Expands Medidata Pact
Will offer customers Medidata’s next-gen EDC and RTSM systems
